KRN 2391
Alternative Names: KRN 2039Latest Information Update: 22 Sep 2004
Price :
$50 *
At a glance
- Originator Kirin Brewery
- Developer Kirin Brewery; Nippon Shinyaku
- Class Anti-ischaemics; Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies; Small molecules; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias
Most Recent Events
- 22 Sep 2004 Discontinued - Phase-II for Angina pectoris in Japan (PO)
- 22 Sep 2004 Discontinued - Preclinical for Arrhythmias in Japan (unspecified route)
- 14 Oct 1998 No Development Reported - Preclinical for Arrhythmias in Japan (Unknown route)